Deerfield Management’s Pacific Biosciences PACB Stock Holding History

Deerfield Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-650,000	Closed	-$7.53M	–	108
2023 Q1	$7.53M	Buy	+650,000	New	+$6.46M	0.17%	77
2022 Q4	–	Sell	-2,021,000	Closed	-$11.7M	–	115
2022 Q3	$11.7M	Buy	+2,021,000	New	+$11.6M	0.23%	77
2021 Q2	–	Sell	-468,000	Closed	-$15.6M	–	153
2021 Q1	$15.6M	Sell	468,000 -107,000	-19%	-$3.75M	0.33%	83
2020 Q4	$14.9M	Buy	+575,000	New	+$9.77M	0.29%	84
2016 Q3	–	Sell	-63,072	Closed	-$444K	–	100
2016 Q2	$444K	Buy	+63,072	New	+$576K	0.02%	102
2016 Q1	–	Sell	-1,388,000	Closed	-$18.2M	–	111
2015 Q4	$18.2M	Sell	1,388,000 -797,771	-36%	-$7.16M	0.74%	48
2015 Q3	$8M	Buy	2,185,771 +699,910	+47%	+$3.42M	0.31%	75
2015 Q2	$8.56M	Sell	1,485,861 -1,562,449	-51%	-$9.04M	0.29%	76
2015 Q1	$17.8M	Sell	3,048,310 -2,072,461	-40%	-$14.3M	0.58%	46
2014 Q4	$40.1M	Buy	5,120,771 +721,439	+16%	+$4.62M	1.44%	24
2014 Q3	$21.6M	Sell	4,399,332 -295,871	-6%	-$1.55M	0.79%	46
2014 Q2	$29M	Sell	4,695,203 -710,907	-13%	-$3.56M	1.17%	28
2014 Q1	$28.9M	Buy	5,406,110 +1,054,848	+24%	+$6.67M	1.18%	29
2013 Q4	$22.8M	Sell	4,351,262 -533,106	-11%	-$2.45M	1.18%	31
2013 Q3	$27M	Hold	4,884,368	–	–	1.25%	33
2013 Q2	$12.4M	Buy	+4,884,368	New	+$12.2M	0.58%	59

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management's PACB Position: Q2 2023 in Review

Deerfield Management sold out of Pacific Biosciences (PACB) in Q2 2023, closing a stake of 650,000 shares — an estimated $7.53M sold.

Deerfield Management first reported a position in PACB in Q2 2013 and held it in 16 quarters. The position peaked at $40.1M in Q4 2014. 272 funds tracked by Wall St. Rank hold PACB as of Q2 2023.

Deerfield Management reported no remaining Pacific Biosciences position as of Q2 2023 after selling out during the quarter.
Deerfield Management sold 650,000 Pacific Biosciences shares in Q2 2023, an estimated $7.53M.
Deerfield Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 16 quarters.
Deerfield Management's Pacific Biosciences position peaked at $40.1M in Q4 2014.
272 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2023.

Based on Deerfield Management's 13F filing for Q2 2023, filed 14 Aug 2023.